21 algorithm-development-"Multiple"-"Simons-Foundation"-"Prof"-"UNIS"-"St" PhD positions at Leiden University
Sort by
Refine Your Search
-
motivated PhD student to join the Bioorganic Synthesis group on a project which aims to develop innovative chemical tools to study mucin degradation. Bacterial enzymes that degrade host mucins play key roles
-
are seeking a highly motivated PhD student to join the Bioorganic Synthesis group on a project which aims to develop innovative chemical tools to study mucin degradation. Bacterial enzymes that degrade host
-
: Organisational differences (1.0 fte) For our NWO-funded project “From ‘what went wrong’ to ‘what works well?’ Using Safety 2 principles to develop new cybersecurity solutions”, we are looking for a PhD candidate
-
-users and teams (1.0 fte) For our NWO-funded project “From ‘what went wrong’ to ‘what works well?’ Using Safety 2 principles to develop new cybersecurity solutions”, we are looking for a PhD candidate
-
to develop new cybersecurity solutions”, we are looking for a PhD candidate interested in building positive cybersecurity solutions for organisations. In this five-year project, we aim to develop cybersecurity
-
Apply now PhD in organisational cybersecurity: End-users and teams (1.0 fte) For our NWO-funded project “From ‘what went wrong’ to ‘what works well?’ Using Safety 2 principles to develop new
-
interdisciplinary team and explore the complex relationship between behavior and brain health. This project focuses on developing novel measures of brain health by analyzing everyday behavioral patterns. What you
-
, synthetic chemists team up with immunologists from the Leiden University Medical Centre and computational scientists from the TU Delft to develop the next generation of synthetic CAAR cell therapy for serious
-
on the development of drugs modulating immunometabolism. Immune dysregulation contributes to many human diseases, including cancer, cardiovascular disease, chronic infections, and neurodegeneration. Developing drugs
-
scientists from the TU Delft to develop the next generation of synthetic CAAR cell therapy for serious autoimmune conditions. The project is a shared position between the CBI-department (Leiden University) and